Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Ann Hepatol ; 29(3): 101287, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38266674

RESUMEN

INTRODUCTION AND OBJECTIVES: Autoimmune hepatitis (AIH) is a prevalent noninfectious liver disease. However, there is currently a lack of noninvasive tests appropriate for evaluating liver fibrosis in AIH patients. The objective of this study was to develop and validate a predictive model for noninvasive assessment of significant liver fibrosis (S ≥ 2) in patients to provide a reliable method for evaluating liver fibrosis in individuals with AIH. MATERIALS AND METHODS: The clinical data of 374 AIH patients were analyzed. A prediction model was established through logistic regression in the training set, and bootstrap method was used to validate the models internally. In addition, the clinical data of 109 AIH patients were collected for external verification of the model.The model was expressed as a nomogram, and area under the curve (AUC) of the receiver operating characteristic (ROC), calibration curve, and decision curve analysis were used to evaluate the accuracy of the prediction model. RESULTS: Logistic regression analysis revealed that age, platelet count (PLT), and the A/G ratio were identified as independent risk factors for liver fibrosis in AIH patients (P < 0.05). The diagnostic model that was composed of age, PLT and A/G was superior to APRI and FIB-4 in both the internal validation (0.872, 95%CI: 0.819-0.924) and external validation (0.829, 95%CI: 0.753-0.904). CONCLUSIONS: Our predictive model can predict significant liver fibrosis in AIH patients more accurately, simply, and noninvasively.


Asunto(s)
Hepatitis Autoinmune , Cirrosis Hepática , Nomogramas , Valor Predictivo de las Pruebas , Curva ROC , Humanos , Hepatitis Autoinmune/complicaciones , Hepatitis Autoinmune/sangre , Hepatitis Autoinmune/diagnóstico , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/sangre , Femenino , Masculino , Persona de Mediana Edad , Adulto , Recuento de Plaquetas , Modelos Logísticos , Factores de Riesgo , Reproducibilidad de los Resultados , China/epidemiología , Técnicas de Apoyo para la Decisión , Área Bajo la Curva , Factores de Edad , Biomarcadores/sangre , Estudios Retrospectivos , Adulto Joven , Pueblo Asiatico , Anciano , Pueblos del Este de Asia
2.
Postgrad Med J ; 100(1185): 482-487, 2024 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-38366872

RESUMEN

BACKGROUND: Psoas abscess (PA) is an uncommon disease that has been increasingly reported in the recent years. We reviewed patients with PA and analyzed their clinical characteristics to improve our understanding of this rare disorder. METHODS: We retrospectively reviewed the clinical presentations, microbiology, and outcomes of patients with PA between 2011 and 2022 at the Zhejiang Provincial People's Hospital in China. RESULTS: There were 40 adult patients identified with the discharge diagnosis of PA. The mean age was 60 years, and 67.5% of the patients were male. Primary symptoms were typically nonspecific. In all, 20 abscesses were considered secondary, and the most common was infective spondylitis. The most common causative organism for primary PA was Staphylococcus aureus, followed by Escherichia coli, whereas multiple bacterial species were found in secondary abscesses. The overall in-hospital mortality rate was 5%. Patients with secondary PA had a longer hospital stay. CONCLUSION: PA, as a serious infectious condition, usually presents with nonspecific symptoms and laboratory test results, making early diagnosis difficult. These profiles differed from those reported in the present study. The initial clinical status and subsequent imaging studies can lead to favorable outcomes.


Asunto(s)
Absceso del Psoas , Humanos , Absceso del Psoas/diagnóstico , Absceso del Psoas/microbiología , Absceso del Psoas/terapia , Masculino , Persona de Mediana Edad , Femenino , Estudios Retrospectivos , China/epidemiología , Anciano , Adulto , Mortalidad Hospitalaria , Tiempo de Internación/estadística & datos numéricos , Infecciones Estafilocócicas/diagnóstico , Staphylococcus aureus/aislamiento & purificación , Antibacterianos/uso terapéutico , Infecciones por Escherichia coli/diagnóstico , Escherichia coli/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA